In a preliminary order released last week, U.S. District Judge Douglas Woodlock in Massachusetts appeared to side with Google's interpretations of the patent in question, a stance that could bode well for the search giant as the case moves on.
Some think it means Apple is softening its stance on patents.
Suddenly, the American stance, that without patent protection there would be no drugs, seemed hollow.
Google's stance on the patent matter has always been that they only want them for defensive purposes, so you know this jab must really piss them off.
Even so, expect the rest of the bodies that Google need approval from to take a similarly tough stance on the patent issue.
Entrepreneurs overwhelmingly supported my stance that software patents hamper innovation and need to be abolished, but friends at Microsoft, IBM, and Google were outraged at my recommendation.
In seeking a court order against its rival in the two large European markets, Samsung indicated a more aggressive stance in its expanding patent battle with Apple.
Still, Mr. Noonan, who is an author of Patent Docs, a blog on biotech patent issues, said the government's stance would endanger innovation because the same philosophy against patenting products isolated from nature might be extended to protein-based drugs and antibiotics.
Samsung's primary goal in its legal wrangling with Apple appears to be to counter that company's aggressive stance with regards to patent litigation, as indicated by another statement received by Reuters from the Korean company.
The stance of the European Patent office is also discussed and how its regulation is much more flexible, opening up greater competition than is possible in the US.
